Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Payables (2023 - 2025)

Baird Medical Investment Holdings has reported Payables over the past 3 years, most recently at $12.2 million for Q4 2025.

  • For Q4 2025, Payables fell 29.75% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.2 million, down 29.75%, while the annual FY2025 figure was $12.2 million, 29.75% down from the prior year.
  • Payables for Q4 2025 was $12.2 million at Baird Medical Investment Holdings, down from $14.0 million in the prior quarter.
  • Over five years, Payables peaked at $17.4 million in Q4 2024 and troughed at $8.7 million in Q4 2023.
  • A 3-year average of $13.1 million and a median of $13.1 million in 2025 define the central range for Payables.
  • Biggest five-year swings in Payables: skyrocketed 99.83% in 2024 and later decreased 29.75% in 2025.
  • Year by year, Payables stood at $8.7 million in 2023, then surged by 99.83% to $17.4 million in 2024, then fell by 29.75% to $12.2 million in 2025.
  • Business Quant data shows Payables for BDMD at $12.2 million in Q4 2025, $14.0 million in Q2 2025, and $17.4 million in Q4 2024.